Immunome: A Lately Acquired Lead Asset And A Small Market (NASDAQ:IMNM)
Avisol Capital Companions is made up of a workforce of medical consultants, finance professionals and techies, all of whom make investments their very own cash within the picks they share. They purpose to assist readers discover the center floor between worth and progress investing, as they demystify the biopharma business.
They lead the investing group Whole Pharma Tracker the place they provide a month-to-month up to date catalyst database, an investability scoring system for fast reference concepts, and direct entry in chat for dialogue and questions. Be taught extra.
Analyst’s Disclosure: I/we’ve no inventory, choice or related spinoff place in any of the businesses talked about, and no plans to provoke any such positions throughout the subsequent 72 hours. I wrote this text myself, and it expresses my very own opinions. I’m not receiving compensation for it (aside from from Searching for Alpha). I’ve no enterprise relationship with any firm whose inventory is talked about on this article.
Searching for Alpha’s Disclosure: Previous efficiency isn’t any assure of future outcomes. No suggestion or recommendation is being given as as to if any funding is appropriate for a specific investor. Any views or opinions expressed above might not replicate these of Searching for Alpha as a complete. Searching for Alpha will not be a licensed securities supplier, dealer or US funding adviser or funding financial institution. Our analysts are third celebration authors that embrace each skilled buyers and particular person buyers who is probably not licensed or licensed by any institute or regulatory physique.
